In 2023, Merck’s cancer drug Keytruda surpassed the COVID-19 vaccine Comirnaty to become the top-selling pharmaceutical product worldwide, generating around $25 billion in revenue. Comirnaty came in second place, with total revenues of $15.3 billion, followed closely by Humira, which generated $14.4 billion in revenue.
Humira is primarily used to treat rheumatoid and psoriatic arthritis, but it is also used to treat a range of other medical conditions, including Crohn’s disease, ankylosing spondylitis, ulcerative colitis, psoriasis, uveitis, and some other autoimmune diseases. The drug is administered through subcutaneous injections and was first approved by the FDA in 2002.
Best-selling pharmaceutical products worldwide
| Rank | Drug | Company | Sales revenue (in billion US dollars) |
|---|---|---|---|
| 1 | Keytruda | Merck & Co. | 25 |
| 2 | Comirnaty | BioNTech/Pfizer | 15.30 |
| 3 | Humira | AbbVie | 14.40 |
| 4 | Ozempic | Novo Nordisk | 13.90 |
| 5 | Eylea | Bayer/Regeneron | 12.90 |
| 6 | Eliquis | BMS | 12.20 |
| 7 | Biktarvy | Gilead | 11.90 |
| 8 | Dupixent | Sanofi/Regeneron | 11.60 |
| 9 | Stelara | J&J | 10.90 |
| 10 | Darzalex | J&J | 9.70 |
Have you read?
These American Company Slogans (and Taglines) Everyone Knows.
America’s Best Investment Advisory Firms, 2023.
Report: These Are The Most Eaten Foods in the World, 2023.
Most expensive cars in the world, 2023.
These Are the Richest Cities in the World, 2023.
Richest Professional Football Clubs In The World, 2023.
Add CEOWORLD magazine as your preferred news source on Google News
Follow CEOWORLD magazine on: Google News, LinkedIn, Twitter, and Facebook.License and Republishing: The views in this article are the author’s own and do not represent CEOWORLD magazine. No part of this material may be copied, shared, or published without the magazine’s prior written permission. For media queries, please contact: info@ceoworld.biz. © CEOWORLD magazine LTD
